Abstract
Biliary atresia (BA) is a severe hepatobiliary disease in infancy characterized by a progressive, fibro-obliterative process affecting extrahepatic as well as intrahepatic bile ducts, leading to early liver cirrhosis. The etiology is unknown but is most likely multifactorial. Kasai hepatic portoenterostomy can provide effective palliation and successful bile drainage which correlates with the patient’s age at operation. Screening by stool color card is useful in early identification of BA from infants with cholestasis and timely portoenterostomy to restore bile drainage. Recent studies showed a clear disadvantage for those infants operated on later than 90 days of age. Postsurgical management includes prevention of cholangitis, nutritional support to overcome malabsorption and malnutrition, and minimization of the sequelae of portal hypertension. About 80 % of children with successful portoenterostomy can survive more than 10 years with their native liver and achieve good quality of life. However, a large proportion of children with BA will require liver transplantation at some stage, especially if the Kasai portoenterostomy is unsuccessful. In the largest follow-up study of BA children who underwent liver transplantation, the 10-year patient and actuarial graft survival was 86 % and 73 %, respectively. While the improved medical and surgical management and liver transplantation have prolonged survival, further investigation on the etiology and pathogenesis of BA will hopefully provide effective therapy to intervene the development and progression of the disease in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, et al. Biliary atresia: current concepts and research directions: summary of a symposium. Hepatology. 1996;23:1682–92.
Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374:1704–13.
McKiernan PJ, Bajer AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet. 2000;355:25–9.
Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B. Epidemiology of biliary atresia in France: a national study. J Hepatol. 1999;31:1006–13.
Houwen RH, Kerremans II, van Steensel-Moll HA, van Romunde LK, Bijleveld CM, Schweizer P. Time-space distribution of extrahepatic biliary atresia in the Netherlands and West Germany. Z Kinderchir. 1988;43:68–71.
Strickland AD, Shannon K. Studies in the etiology of extrahepatic biliary atresia: time-space clustering. J Pediatr. 1982;100:749–53.
Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ. Epidemiology of biliary atresia: a population-based study. Pediatrics. 1997;99:376–82.
Shim WK, Kasai M, Spence MA. Racial influence on the incidence of biliary atresia. Prog Pediatr Surg. 1974;6:53–62.
Danks DM, Campbell PE, Jack I, Rogers J, Smith AL. Studies of the etiology of neonatal hepatitis and biliary atresia. Arch Dis Child. 1977;52:360–7.
Chiba T, Ohi R, Kamiyama T, Nio M, Ibrahim M. Japanese biliary atresia registry. In: Ohi R, editor. Biliary atresia. Tokyo: ICOM Associates; 1991. p. 79–86.
Lin YC, Chang MH, Liao SF, et al. Decreasing rates of biliary atresia in Taiwan: a survey, 2004–2009. Pediatrics. 2011;128:e530–6.
Vic P, Gestas P, Mallet EC, Arnaud JP. Biliary atresia in French Polynesia. Retrospective study of 10 years. Arch Pediatr. 1994;1:646–51.
Karrer FM, Lilly JR, Stewart BA, et al. Biliary atresia registry, 1976–1989. J Pediatr Surg. 1990;35:1076–81.
Carmi R, Magee CA, Neill CA, Karrer FM. Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations. Am J Med Genet. 1993;45:683–93.
Davenport M, Tizzard S, Undrehill J, et al. The biliary atresia splenic malformation syndrome: a 28-year single center retrospective study. J Pediatr. 2006;149:393–400.
Fjaer RB, Bruu AL, Nordbo SA. Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant. 2005;9:68–73.
Hsu HY, Chang MH, Ni YH, et al. Cytomegalovirus infection and proinflammatory cytokine activation modulate the surface immune determinant expression and immunogenicity of cultured murine extrahepatic bile duct epithelial cells. Clin Exp Immunol. 2001;126:84–91.
Morecki R, Glaser JH, Cho S, Balistreri WF, Horwitz MS. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1984;310:1610.
Riepenhoff-Talty M, Gouvea V, Evans MJ, Svensson L, Hoffenberg E, Sokol RJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis. 1996;174:8–15.
Szavay PO, Leonhardt J, Czech-Schmidt G, Petersen C. The role of reovirus type 3 infection in an established murine model for biliary atresia. Eur J Pediatr Surg. 2002;12:248–50.
Ripenhoff-Talty M, Schaekel K, Clark HF, Muller W, Uhnoo I, Rossi T, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res. 1993;33:394–9.
Jevon GP, Dimmick JE. Biliary atresia and cytomegalovirus infection: a DNA study. Pediatr Dev Pathol. 1999;2:11–4.
Saito T, Shinozaki K, Matsunaga T, et al. Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct. J Hepatol. 2004;40:203–11.
Bobo L, Ojeh C, Chiu D, Machado A, Colombani P, Schwarz K. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res. 1997;41:229–34.
Kahn E. Biliary atresia revisited. Pediatr Dev Pathol. 2004;7:109–24.
Bezerra JA, Tiao G, Ryckman FC, Alonso M, Sabla GE, Shneider B, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002;360:1653–9.
Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, et al. Biliary atresia is associated with CD+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56:79–87.
Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology. 2012;55:1130–8.
Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, Mcneal MM, et al. Obstruction of extrahepatic ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest. 2004;114:322–9.
Erickson N, Mohanty SK, Shivakumar P, Sabla G, Chakraborty R, Bezerra JA. Temporal-spatial activation of apoptosis and epithelial injury in murine experimental biliary atresia. Hepatology. 2008;47:1567–77.
Mazziotti MV, Willis LK, Heuckeroth RO, LaRegina MC, Swanson PE, Overbeek PA, et al. Anomalous development of the hepatobiliary system in the Inv mice. Hepatology. 1999;30:372–8.
Schon P, Tsuchiya K, Lenoir D, Mochizuki T, Guichard C, Takai S, et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in the left-right axis development and biliary atresia. Hum Genet. 2002;110:157–65.
Zhang DY, Sabla G, Shivakumar P, Tiao G, Sokol RJ, Mack C, et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology. 2004;39:954–62.
Balistreri WF. Neonatal cholestasis. J Pediatr. 1985;106:171–84.
Mieli-Vergani G, Howard ER, Portman B, Mowat AP. Late referral for biliary atresia-missed opportunities for effective surgery. Lancet. 1989;1:421–3.
Lai MW, Chang MH, Hsu SC, Hsu HC, Su CT, Kao CL, et al. Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: a prospective study. J Pediatr Gastroenterol Nutr. 1994;18:121–7.
Matsui A, Ishikawa T. Identification of infants with biliary atresia in Japan. Lancet. 1994;343:925.
Matsui A, Dodorki M. Screening for biliary atresia. Lancet. 1995;345:1181.
Chen SM, Chang MH, Du JC, Lin CC, Chen AC, Lee HC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117:1147–54.
Hsiao CH, Chang MH, Chen HL, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology. 2008;47:1233–40.
Hung PY, Chen CC, Chen WJ, Lai HS, Hsu WM, Lee PH, et al. Long-term prognosis of patients with biliary atresia: a 25 year summary. J Pediatr Gastroenterol Nutr. 2006;42:190–5.
Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: potential for a community-based programme. J Med Screen. 2003;10:112–6.
Palmer RH, Ezhuthachan S, Newman C, Maisels MJ, Testa MA. Management of hyperbilirubinemia in newborns: measuring performance using a benchmarking model. Pediatrics. 2004;114:902.
Ikeda S, Sera Y, Ohshiro H, et al. Gall bladder contraction in biliary atresia: a pitfall of ultrasound diagnosis. Pediatr Radiol. 1998;28:451–3.
Lee HJ, Lee SM, Park WH, Choi SO. Objective criteria of triangular cord sign in biliary atresia on US scan. Radiology. 2003;229:395–400.
Roquete ML, Ferreira AR, Fagundes ED, Gastro LP, Penna FJ. Accuracy of echogenic periportal enlargement image in ultrasonographic exams and histopathology in differential diagnosis of biliary atresia. J Pediatr. 2008;84:331–6.
Gilmour SM, Hershkop M, Reifen R, Gilday D, Roberts EA. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome I. Nucl Med. 1997;38:1279–82.
Jaw TW, Kuo YT, Liu GC, Chen SH, Wang CK. MR cholangiography in the evaluation of neonatal cholestasis. Radiology. 1999;212:249–56.
Azar G, Beneck D, Lane B, Markowitz J, Daum F, Kahn E. Atypical morphologic presentation of biliary atresia and value of serial biopsies. J Pediatr Gastroenterol Nutr. 2002;34:212–5.
Ohi R. Surgery for biliary atresia. Liver. 2001;21:175–82.
Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997–2000. J Pediatr. 2006;148:467–74.
Serinet MO, Wildhaber BE, Broue P, et al. Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics. 2009;123:1280–6.
Nio M, Ohi R, Miyano T, et al. Five- and 10 year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg. 2003;38:997–1000.
Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151:659–65.
Tan CE, Davenport M, Driver M, et al. Does morphology of the extrahepatic remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg. 1994;29:1459–64.
Bu LN, Chen HL, Chang CJ, et al. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg. 2003;38:590–3.
Wu ET, Chen HL, Ni YH, et al. Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int. 2001;17:390–5.
Watanabe M, Kaneko TH, Komuro H, et al. Intrahepatic biliary cyst in children with biliary atresia who have had a Kasai operation. J Pediatr Surg. 2007;42:1185–9.
Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M. Serial circulating markers of inflammation in biliary atresia-evolution of the post-operative inflammatory process. Hepatology. 2007;46:180–7.
Lykavieris P, Chardot C, Sokhn M, Gauthier F, Valayer J, Bernard O. Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology. 2005;41:366–71.
Hol L, van den Bos IC, Hussain SM, Zondervan PE, de Man RA. Hepatocellular carcinoma complicating biliary atresia after Kasai portoenterostomy. Eur J Gastroenterol Hepatol. 2008;20:227–31.
Muraji T, Nio M, Ohhama Y, Hashimoto T, Iwanaka T, Takamatsu H, et al. Postoperative corticosteroid therapy for bile drainage in biliary atresia – a nationwide survey. J Pediatr Surg. 2004;39:1803–5.
Escobar MA, Jay CL, Brooks RM, et al. Effects of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg. 2006;41:99–103.
Davenport M, Stringer MD, Tizzard SA, et al. Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology. 2007;46:1821–7.
Willot S, Uhlen S, Michaud L, et al. Effect of ursodeoxycholic acid on liver function in children with surgery for biliary atresia. Pediatrics. 2008;122:e1236–41.
Pierro A, Loletzko B, Carnielli V, et al. Resting energy expenditure is increased in infants and children with extrahepatic biliary aresia. J Pediatr Surg. 1989;24:534–8.
Kelly DA, Dvenport M. Current management of biliary atresia. Arch Dis Child. 2007;92:1132–5.
De Russo PA, et al. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology. 2007;46:1632–8.
Utterson EC, Shepherd RW, Sokol RJ, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr. 2005;147:180–5.
Schneider BL, Mazariegos GV. Biliary atresia: a transplant perspective. Liver Transpl. 2007;13:1482–95.
Chen CL, Concejero A, Wang CC, et al. Living donor liver transplantation for biliary atresia: a single-center experience with first 100 cases. Am J Transplant. 2006;6:2672–9.
Barshes NR, Lee TC, Balkrishnan R, et al. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11(10):1193–200.
Otte JB. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr Transplant. 2002;6(5):378–87.
Kuroda T, Saeki M, Morikawa N, Fuchimoto Y. Biliary atresia and pregnancy: puberty may be an important point for predicting the outcome. J Pediatr Surg. 2005;40:1852–5.
Lien TH, Chang MH, Wu JF, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology. 2011;53:202–8, 71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hsu, HY., Chang, MH. (2014). Biliary Atresia. In: Murray, K., Horslen, S. (eds) Diseases of the Liver in Children. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9005-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9005-0_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9004-3
Online ISBN: 978-1-4614-9005-0
eBook Packages: MedicineMedicine (R0)